RE:RE:approaching # of anticipated inflection points in Woundcareall the really big news releases look to be coming between April 1st and June 30th (2nQ) but we can hope they might be sooner. The partnering for the human wound care products and anything from MTEC will be the real biggies.
Kane Wound Care and Surgical (KWCS)
• Commercialization vehicle target Q2 2021
• $70M valuation estimated based on Strategic Partner investment
• First commercial sale target Q1 2022
• Kane would have 90% Equity ownership
• Provides administrative, R&D and Product development services
Advanced discussions with multiple potential partners
– $7M equity investment
– partner would get 9.9% equity stake in KWCS
– Exclusive US rights to current and future Kane technology and products
– Products to be purchased by strategic partner from KWCS and resold through existing sales network